Name: The First Move Matters: Personalising First-Line EGFR+ NSCLC Treatment for Optimal Survival Outcomes
Start: 2026-09-13T13:45:00+09:00
End: 2026-09-13T14:45:00+09:00

Sign up for news updates

Timely and relevant thoracic oncology news brought to you by the only true global association dedicated to the multi-disciplinary study of lung cancer.

Timely and relevant thoracic oncology news brought to you by the only true global association dedicated to the multi-disciplinary study of lung cancer.